VT-1917

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameVT-1917
Drug Alias NameVT-1917
ClassificationOther
Mechanisms of ActionToll-like receptor antagonistsTopoisomerase IV inhibitors
TargetsTopoisomerase IV
Therapy Area/IndicationsOtitis Media
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesVyome Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesVyome Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsOtitis Media
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A